[Antibiotics used for paratyphi B infections resistant to classical treatment and the results of their use].
Salmonella paratyphi B is a pathogenic agent causing outbreaks and keeping epidemiologic importance. The classical treatment of this disease is made by ampicillin, chloramphenicol, and co-trimoxazole in resistant strain. The resistant strains tends to cause a treatment problem. We report treatment and antibiogram results of 48 patients exactly diagnosed as paratyphi B infection by clinic and laboratory evaluation. These patients came to pediatric clinic of Erzincan state Hospital from Erzincan town and its backgrounds and had ages between 3 months and 5 years. All isolates were resistant to ampicillin, chloramphenicol and cotrimoxazole but usually sensitive to 3. generation cephalosporins (Cefotaxime had greatest sensitivity ratio with 79.1%) and amikacin.
Taşdemir
H A
HA
Erzincan Devlet Hastanesi, Cocuk Hastaliklari Uzmani.
Albayrak
D
D
D000583:Amikacin / Q000494:pharmacology / Q000627:therapeutic use*; D000668:Ampicillin Resistance; D002439:Cefotaxime / Q000494:pharmacology / Q000627:therapeutic use; D002511:Cephalosporins / Q000494:pharmacology / Q000627:therapeutic use*; D002675:Child, Preschool; D002701:Chloramphenicol / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D006801:Humans; D007223:Infant; D010284:Paratyphoid Fever / Q000188:drug therapy*; D012475:Salmonella / Q000187:drug effects*; D012484:Salmonella paratyphi B / Q000187:drug effects*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000494:pharmacology
D002511:Cephalosporins; D002701:Chloramphenicol; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000583:Amikacin; D002439:Cefotaxime
Klasik tedaviye direnç kazanmiş olan paratifo B enfeksiyonunda, kullanilabilecek duyarli antibiyotikler ve sonuçlari.